Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapy.
Aiming
A
Yang
Martin S
MS
King
Lixin
L
Han
Jeffrey D
JD
Isaacson
Toby
T
Mueller
David R
DR
Grimm
C Brun
CB
Scott
David A
DA
Katz
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D022762:CCAAT-Enhancer-Binding Proteins / Q000235:genetics*; D002784:Cholesterol / Q000032:analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D006949:Hyperlipidemias / Q000235:genetics*; D011446:Prospective Studies; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors; D014280:Triglycerides / Q000032:analysis
D022762:CCAAT-Enhancer-Binding Proteins; D004268:DNA-Binding Proteins; C497387:SREBF1 protein, human; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors; D014280:Triglycerides; D002784:Cholesterol